Navigation Links
Rheumatoid Arthritis: World Drug Market 2011-2021
Date:11/2/2011

NEW YORK, Nov. 2, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Rheumatoid Arthritis: World Drug Market 2011-2021

http://www.reportlinker.com/p0663865/Rheumatoid-Arthritis-World-Drug-Market-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

How will the market for rheumatoid arthritis treatments perform from 2011? Visiongain's report shows you potential revenues to 2021, discussing opportunities and prospects.

Discover rheumatoid arthritis drug revenues at total world, submarket, product and national levels. Through our research and analysis we aim to save you time and help in your decisions. 

See how drugs such as Celebrex, Arcoxia, Humira, Remicade, Enbrel, MabThera and Cimzia can perform to 2021, finding potential revenues. How will competition affect the market? 

Discover commercial prospects for biological and non-biological drugs for rheumatoid arthritis. Receive data you need for non-steroidal anti-inflammatory drugs (NSAIDs) and other products.

There is a strong R&D pipeline for treating inflammatory diseases. We cover NSAIDs, corticosteroids and biologics for rheumatoid arthritis. Find R&D trends.

Our report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Analysis with revenues, future growth rates, market shares, opinions and discussions

In our report you find revenue forecasts, growth rates, market shares, qualitative analyses (incl. SWOT), an R&D review and opinions from our survey. You receive
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
2. Rheumatoid Arthritis Market Forecast
3. HYCOR Broadens Diagnostic Offerings, Announces Agreements to License Biomarkers for Celiac Disease and Rheumatoid Arthritis
4. Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
5. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
6. Approved Biologic Therapies in Rheumatoid Arthritis Show Further Evidence of Efficacy and Reduction in Joint Damage at the 2011 European League Against Rheumatisms Congress
7. Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop NIMBLE Personalized Medicine Program for Rheumatoid Arthritis Patients
8. Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients
9. Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients
10. Reportlinker Adds U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
11. Reportlinker Adds Epidemiology: Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... BALTIMORE and LONDON , Aug. 28, ... volunteers in the UK, The Gambia and ... of an series of safety trials of potential vaccines aimed at ... the current outbreak in West Africa . ... US National Institutes of Health (NIH) and GlaxoSmithKline, are to be ...
(Date:8/28/2014)... CHARLOTTE, N.C. , Aug. 28, 2014 /PRNewswire/ ... innovation marketplace, today announced a worldwide search for ... of the senior population.  Promising ideas uncovered through ... presented to leading medical device manufacturers and healthcare ... to improve the lives of individuals age 65 ...
(Date:8/28/2014)... 28, 2014 According to a ... Identification (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) ... Forecast, 2014 - 2020" the global radiofrequency identification (RFID) ... and is expected to grow at a CAGR of ... value of USD 5.3 billion in 2020. ...
Breaking Medicine Technology:Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5
... 16, 2010 See video from Siemens Corporation ... Say so-long to the days of black ... to MRI and PET, medical imaging is faster, ... way medicine is practiced. Thanks to years of ...
... Unsustainable Medicare reimbursement rates for home medical equipment ... providers will occur as a result of Medicare,s bidding ... nine of the largest metropolitan areas in the U.S. ... Dallas-Fort Worth, Kansas City, Miami, Orlando, Pittsburgh, and Riverside, ...
Cached Medicine Technology:VIDEO from Siemens Corporation Available on thenewsmarket.com: Amazing Medical Images: Diagnosing in the Digital Age 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 3
(Date:8/28/2014)... A subset of patients with stage III colon ... therapy, according to a new study in ... the American Gastroenterological Association. , When added to the ... irinotecan therapy improved overall survival rates for patients with ... in about 10 to 20 percent of colorectal cancers. ...
(Date:8/28/2014)... over who identify themselves as ,old, feel worse about ... have lower value than younger age groups. , New ... ,Being old and ill, across different countries: social status, ... from the European Social Survey. Respondents, who were all ... health., The researchers found that those living in societies ...
(Date:8/28/2014)... Manchester scientists are working out how to safely increase ... potentially offering improved local control and survival. , Standard ... a combination of radiotherapy and chemotherapy. Traditionally this is ... may not always be enough to stop tumour growth. ... the cancerous tissue varies between patients and depends on ...
(Date:8/28/2014)... 2014 Vaccine market - the once ... among other healthcare industry sectors and sub-circles in the ... vaccine with respect to evolving and spreading infectious diseases. ... an improved understanding for a well-balanced life and improved ... has led to new opportunities for manufacturing novel preventive ...
(Date:8/28/2014)... August 28, 2014 AmeriPride Services, a ... today announced the launch of its new Customer Portal, ... even easier and more convenient for customers. The industry-leading ... and better communicate with the company. , Features of ... Access, download and pay bills online ...
Breaking Medicine News(10 mins):Health News:Drug shows promise for subset of stage III colon cancer patients 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3
... The Medicare drug program is on its last lap of seeking ... of the plans to rest// with three major insurance players. ... with AARP as its official endorsers and a financial agreement with ... for the drug program by Medicare. ,80 companies have ...
... have been found to be alive in America today. ... management of the disease. // ,However it has ... do suffer from debilitating fatigue making normal activities of life ... California at Los Angeles found that not all survivors suffer ...
... included bestowing nurses and pharmacists with the right to ... and pharmacists can undertake extra training in order to ... to tonsillitis. ,Many nurses already run their ... prescribe drugs even for long-term conditions such as asthma ...
... action against smoking in Scotland, it would stop sales of tobacco ... it. ,Ministers have not decided whether to back the ... determination to reduce smoking rates in Scotland. ,In the ... a member of the expert group, "Smoking is far worse than ...
... non-typical sleep times has the ability to improve an ... Sleep Medicine at Brigham and Women’s Hospital and Harvard ... in order to find out the effectiveness of melatonin. ... travelers with jet lag. br> ,The findings appear in ...
... say that percutaneous image-guided biopsy is of a great ... accurately// diagnosing and predicting clinical outcomes. The researchers arrived ... in 126 patients. They found that the biopsy results ... who were to undergo surgery, tumor ablation, chemotherapy or ...
Cached Medicine News:Health News:Breast Cancer Survivors Growing in Numbers 2Health News:Melatonin Can Help Nighttime Workers Sleep 2Health News:Melatonin Can Help Nighttime Workers Sleep 3Health News:Image-Guided Biopsy Can Alter Clinical Decisions In Kidney Patients 2
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
Medicine Products: